Treatment failure of direct oral anticoagulants in anti-phospholipid syndrome

Scand J Rheumatol. 2018 Sep;47(5):427-428. doi: 10.1080/03009742.2017.1369156. Epub 2018 Jan 3.

Authors

Sja Johnsen¹, M B Lauvsnes¹, R Omdal^{1

2}

Affiliations

¹ a Department of Internal Medicine, Clinical Immunology Unit , Stavanger University Hospital , Stavanger , Norway.
² b Department of Clinical Science, Faculty of Medicine and Dentistry , University of Bergen , Bergen , Norway.

PMID: 29297243
DOI: 10.1080/03009742.2017.1369156

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Antiphospholipid Syndrome / complications
Antiphospholipid Syndrome / drug therapy*
Dabigatran / adverse effects*
Dabigatran / therapeutic use
Female
Humans
Male
Middle Aged
Thromboembolism / drug therapy
Thromboembolism / etiology*
Treatment Failure

Substances

Anticoagulants
Dabigatran